BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21450573)

  • 21. Superior exercise performance in lifelong Tibetan residents of 4,400 m compared with Tibetan residents of 3,658 m.
    Curran LS; Zhuang J; Droma T; Moore LG
    Am J Phys Anthropol; 1998 Jan; 105(1):21-31. PubMed ID: 9537925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure.
    Agostoni P; Cattadori G; Guazzi M; Bussotti M; Conca C; Lomanto M; Marenzi G; Guazzi MD
    Am J Med; 2000 Oct; 109(6):450-5. PubMed ID: 11042233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate dynamics in heart transplantation patients during a treadmill cardiopulmonary exercise test: a pilot study.
    Carvalho VO; Pascoalino LN; Bocchi EA; Ferreira SA; Guimarães GV
    Cardiol J; 2009; 16(3):254-8. PubMed ID: 19437401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen uptake kinetics and cardiopulmonary performance in lone atrial fibrillation and the effects of sotalol.
    Lok NS; Lau CP
    Chest; 1997 Apr; 111(4):934-40. PubMed ID: 9106572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O2 extraction maintains O2 uptake during submaximal exercise with beta-adrenergic blockade at 4,300 m.
    Wolfel EE; Selland MA; Cymerman A; Brooks GA; Butterfield GE; Mazzeo RS; Grover RF; Reeves JT
    J Appl Physiol (1985); 1998 Sep; 85(3):1092-102. PubMed ID: 9729588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
    Vittorio TJ; Zolty R; Kasper ME; Khandwalla RM; Hirsh DS; Tseng CH; Jorde UP; Ahuja K
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):51-7. PubMed ID: 18287590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
    Krzemiński K; Nazar K; Cybulski G; Mikulski T
    Clin Physiol Funct Imaging; 2006 Nov; 26(6):328-34. PubMed ID: 17042897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol.
    Corrà U; Mezzani A; Giordano A; Bosimini E; Giannuzzi P
    Eur Heart J; 2009 Dec; 30(24):3000-6. PubMed ID: 19406866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxygen uptake response during maximal cycling in hyperoxia, normoxia and hypoxia.
    Peltonen JE; Tikkanen HO; Ritola JJ; Ahotupa M; Rusko HK
    Aviat Space Environ Med; 2001 Oct; 72(10):904-11. PubMed ID: 11601554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-adrenergic or parasympathetic inhibition, heart rate and cardiac output during normoxic and acute hypoxic exercise in humans.
    Hopkins SR; Bogaard HJ; Niizeki K; Yamaya Y; Ziegler MG; Wagner PD
    J Physiol; 2003 Jul; 550(Pt 2):605-16. PubMed ID: 12766243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed Anaerobic Threshold in Heart Failure Patients With Atrial Fibrillation.
    Palermo P; Magrì D; Sciomer S; Stefanini E; Agalbato C; Compagnino E; Chircu CM; Maffessanti F; Teodoru M; Agostoni P
    J Cardiopulm Rehabil Prev; 2016; 36(3):174-9. PubMed ID: 27115075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction.
    Van Tassell BW; Rondina MT; Huggins F; Gilbert EM; Munger MA
    Am Heart J; 2008 Aug; 156(2):315-21. PubMed ID: 18657662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
    Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.